# Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

> **NCT04865133** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 89 (actual)

## Conditions studied

- COVID-19 Infection
- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT04865133
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-31
- **Primary completion:** 2022-09-08
- **Final completion:** 2022-09-08
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04865133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04865133, "Efficacy and Safety of COVID-19 Vaccine in Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04865133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*